Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finke

Showing results (111-120 of 270) with videos related to

Pageof 27
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
Bone marrow scintigraphy using technetium-99m antigranulocyte antibody in malignant lymphomasT Krause, N Eisenmann, M Reinhardt, et al.
Leukemia|August 31, 2016
Allogeneic hematopoietic cell transplantation with double alkylating agents containing reduced-intensity conditioning for patients ⩾60 years with advanced AML/MDSH Bertz, M Lübbert, K Ohneberg, et al.
Bone Marrow Transplantation|June 18, 1999
Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donorsC Berger, H Bertz, C Schmoor, et al.
Bone Marrow Transplantation|April 14, 2009
Non-intensive treatment with low-dose 5-aza-2'-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patientsM Lübbert, H Bertz, B Rüter, et al.
Bone Marrow Transplantation|September 1, 2009
Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allograftingM Lübbert, H Bertz, R Wäsch, et al.
FEBS Letters|October 7, 1996
IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genesJ Wehinger, F Gouilleux, B Groner, et al.
Klinische Wochenschrift|May 15, 1972
[Comparison of cytological and cytochemical classification in 47 cases of acute leukaemia]W Queisser, M Dietrich, J Finke, et al.
Cancer Treatment Reviews|September 1, 1996
Umbilical cord blood: an alternative to the transplantation of bone marrow stem cellsR M Weber-Nordt, E Schott, J Finke, et al.
Zentralblatt Fur Chirurgie|January 1, 1997
[Therapy outcome of patients with soft-tissue sarcoma: retrospective analysis for identifying independent prognostic factors]A Fischer, M Lüdemann, J Schulte-Mönting, et al.
Annals of Hematology|October 1, 1991
Apparent decrease and elimination of BCR/ABL mRNA-expressing residual cells in patients with chronic myelogenous leukemia after allogeneic bone marrow transplantationW Lange, R Herkert, J Finke, et al.
Pageof 27

Showing results (111-120 of 270) with videos related to

Sort By:
Pageof 27
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
Bone marrow scintigraphy using technetium-99m antigranulocyte antibody in malignant lymphomasT Krause, N Eisenmann, M Reinhardt, et al.
Leukemia|August 31, 2016
Allogeneic hematopoietic cell transplantation with double alkylating agents containing reduced-intensity conditioning for patients ⩾60 years with advanced AML/MDSH Bertz, M Lübbert, K Ohneberg, et al.
Bone Marrow Transplantation|June 18, 1999
Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donorsC Berger, H Bertz, C Schmoor, et al.
Bone Marrow Transplantation|April 14, 2009
Non-intensive treatment with low-dose 5-aza-2'-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patientsM Lübbert, H Bertz, B Rüter, et al.
Bone Marrow Transplantation|September 1, 2009
Efficacy of a 3-day, low-dose treatment with 5-azacytidine followed by donor lymphocyte infusions in older patients with acute myeloid leukemia or chronic myelomonocytic leukemia relapsed after allograftingM Lübbert, H Bertz, R Wäsch, et al.
FEBS Letters|October 7, 1996
IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genesJ Wehinger, F Gouilleux, B Groner, et al.
Klinische Wochenschrift|May 15, 1972
[Comparison of cytological and cytochemical classification in 47 cases of acute leukaemia]W Queisser, M Dietrich, J Finke, et al.
Cancer Treatment Reviews|September 1, 1996
Umbilical cord blood: an alternative to the transplantation of bone marrow stem cellsR M Weber-Nordt, E Schott, J Finke, et al.
Zentralblatt Fur Chirurgie|January 1, 1997
[Therapy outcome of patients with soft-tissue sarcoma: retrospective analysis for identifying independent prognostic factors]A Fischer, M Lüdemann, J Schulte-Mönting, et al.
Annals of Hematology|October 1, 1991
Apparent decrease and elimination of BCR/ABL mRNA-expressing residual cells in patients with chronic myelogenous leukemia after allogeneic bone marrow transplantationW Lange, R Herkert, J Finke, et al.
Pageof 27